Study Shows Anti-IL-11 Therapy Extends Male Mouse Lifespan by 22.5%, Female by 25%

Jul 17, 2024, 04:20 PM

A recent study published in Nature has found that inhibiting the pro-inflammatory cytokine interleukin-11 (IL-11) can extend the lifespan of mice by up to 25%. The research demonstrated that both genetic deletion and an anti-IL-11 drug were effective in increasing the lifespans of laboratory mice. The treated mice exhibited fewer age-related health problems and maintained a more youthful appearance, earning them the nickname 'supermodel grannies' in the lab. The median lifespan of male mice increased by 22.5% and female mice by 25%. These findings are significant as anti-IL-11 therapies are already undergoing human clinical trials, raising hopes for potential applications in slowing human ageing.